Clinical trials
Not yet recruiting Phase 3 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AB Science | 1 |
| Cerecin | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Moleac Pte Ltd. | 1 |
| Samsung Pharmaceutical Co., Ltd. | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Universidad de Almeria | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 7 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
| Amyloidosis, Familial | 1 |
| Cardiomyopathies | 1 |
| Cognitive Dysfunction | 1 |
| Heart Diseases | 1 |
| Polyneuropathies | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.